IQOS Takes Lead in UK HnB Market With 99.5% Share

Market
Jan.04.2023

Nina Lyu

 

According to recently released 2022 data from Philip Morris Limited (PML), a subsidiary of Philip Morris International (PMI) in the UK and Ireland, PMI researched 250 UK convenience retailers, 56% of which said they sell heat-not-burn products such as HEETS tobacco sticks priced at £5 (about $5.99) per pack and IQOS ORIGINALS DUO products. IQOS is recognized by UK retailers as the number one heated non-combustible product in the UK market.

 

According to data published by Nielsen, the world's leading market monitoring and data analysis company, testified that IQOS is the number one ranked heated non-combustible product among UK retailers. Nielsen data indicates that PMI's heated tobacco product IQOS has a 99.5% value share of the heat-not-burn market in the UK as of October 2022, meaning that IQOS is the No. 1 product in the category in the UK, including all e-cigarette devices and consumables.

 

PMI has reportedly invested $9 billion in IQOS, with the intention of replacing traditional cigarettes with smokeless alternatives based on a scientific approach.

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12